SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-19-070802
Filing Date
2019-12-09
Accepted
2019-12-09 08:08:12
Documents
7
Period of Report
2019-12-09

Document Format Files

Seq Description Document Type Size
1 6-K a19-24248_26k.htm 6-K 19890
2 EX-99.1 a19-24248_2ex99d1.htm EX-99.1 7936
3 EX-99.2 a19-24248_2ex99d2.htm EX-99.2 5449
4 EX-99.3 a19-24248_2ex99d3.htm EX-99.3 2138
5 GRAPHIC g242482mqi001.gif GRAPHIC 71289
6 GRAPHIC g242482mmi001.jpg GRAPHIC 4158
7 GRAPHIC g242482moi001.jpg GRAPHIC 4158
  Complete submission text file 0001104659-19-070802.txt   146474
Mailing Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000
Business Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000 4588773600
Zealand Pharma A/S (Filer) CIK: 0001674988 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38178 | Film No.: 191274367
SIC: 2834 Pharmaceutical Preparations